• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishGo to App
    Quantisnow Logo

    © 2026 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    68 Biggest Movers From Yesterday

    4/5/22 6:37:16 AM ET
    $AERC
    $ARRY
    $ARTW
    $ATER
    Environmental Services
    Utilities
    Miscellaneous manufacturing industries
    Consumer Discretionary
    Get the next $AERC alert in real time by email

    Gainers

    • GBS Inc. (NASDAQ:GBS) jumped 68% to settle at $1.31 on Monday. Zacks Small-Cap Research issued a note on GBS with an $8 valuation.
    • Aterian, Inc. (NASDAQ:ATER) shares surged 46.8% to close at $3.42 on Monday. Aterian said Cynthia Williams has joined the Company's Board of Directors.
    • Protalix BioTherapeutics, Inc. (NYSE:PLX) gained 41.9% to settle at $1.49. Protalix BioTherapeutics and Chiesi Global Rare Diseases, a unit of Chiesi Farmaceutici S.p.A., announced topline data from the BALANCE Phase 3 trial evaluating pegunigalsidase alfa (PRX–102) for Fabry disease.
    • IO Biotech, Inc. (NASDAQ:IOBT) rose 33.2% to settle at $7.55. IO Biotech recently reported cash and equivalents of $211.5 million as of Dec. 31.
    • VirnetX Holding Corp (NYSE:VHC) jumped 31.3% to close at $2.18.
    • Dingdong (Cayman) Limited (NYSE:DDL) surged 28.8% to close at $4.70.
    • BRC Inc. (NYSE:BRCC) gained 28.7% to close at $28.28.
    • Cognition Therapeutics, Inc. (NASDAQ:CGTX) jumped 28.1% to close at $3.33. Cognition Therapeutics recently posted FY21 loss of $3.13 per share.
    • Twitter, Inc. (NYSE:TWTR) shares surged 27.1% to close at $49.97 after Tesla CEO Elon Musk disclosed a 9.2% passive stake in the social media company.
    • Esports Entertainment Group, Inc. (NASDAQ:GMBL) gained 26.4% to close at $0.90. Esports Entertainment, last month, named Damian Mathews as Finance Chief.
    • Jumia Technologies AG (NASDAQ:JMIA) rose 24.7% to close at $11.82 after the company announced it would make its last mile logistics capabilities available to UPS.
    • Lilium N.V. (NASDAQ:LILM) jumped 24.6% to close at $4.86 after the company announced it has begun flight testing at the ATLAS Flight Test Center in Spain.
    • Poema Global Holdings Corp. (NASDAQ:PPGH) rose 23.7% to close at $12.74 following the completion of its business combination with Gogoro.
    • Oragenics, Inc. (NYSE:OGEN) gained 23.6% to close at $0.4170. Oragenics Director Fred Telling acquired a total of 183,838 shares at an average price of $0.36.
    • Yatsen Holding Limited (NYSE:YSG) jumped 23.1% to close at $0.8432.
    • IN8bio, Inc. (NASDAQ:INAB) jumped 22.4% to close at $4.21.
    • Neoleukin Therapeutics, Inc. (NASDAQ:NLTX) gained 22.3% to settle at $2.25.
    • Precipio, Inc. (NASDAQ:PRPO) surged 21.7% to close at $1.68. The company released Q4 results.
    • Liquid Media Group Ltd. (NASDAQ:YVR) gained 21.4% to close at $0.9681.
    • Singularity Future Technology Ltd. (NASDAQ:SGLY) climbed 21.1% to close at $14.97.
    • Red Cat Holdings, Inc. (NASDAQ:RCAT) surged 21% to close at $2.36 after the company announced a drone order for use in Ukraine.
    • Qutoutiao Inc. (NASDAQ:QTT) jumped 20.8% to close at $1.83.
    • LianBio (NASDAQ:LIAN) gained 20.6% to close at $4.50.
    • Tempest Therapeutics, Inc. (NASDAQ:TPST) rose 20.3% to close at $3.85. Tempest Therapeutics posted FY21 loss of $7.47 per share.
    • Futu Holdings Limited (NASDAQ:FUTU) climbed 19.5% to close at $41.35.
    • Regional Health Properties, Inc. (NYSE:RHE) gained 19.4% to close at $4.12.
    • Nuvectis Pharma, Inc. (NASDAQ:NVCT) gained 19.1% to close at $8.36.
    • Xcel Brands, Inc. (NASDAQ:XELB) surged 18.6% to close at $1.66 after the company issued FY21 sales guidance above analyst estimates.
    • Gracell Biotechnologies Inc. (NASDAQ:GRCL) gained 18.3% to close at $2.65 after BTIG initiated coverage on the stock with a Buy rating and a $18 price target.
    • Nuvve Holding Corp. (NASDAQ:NVVE) climbed 17.7% to close at $8.25. Nuvve Holding recently reported Q4 financial results.
    • iQIYI, Inc. (NASDAQ:IQ) jumped 16.7% to settle at $5.58.
    • Bilibili Inc. (NASDAQ:BILI) rose 16.6% to settle at $32.19 after surging 8% on Friday.
    • Perion Network Ltd. (NASDAQ:PERI) gained 15.9% to close at $26.51 after the company reported better-than-expected Q1 financial results.
    • Full Truck Alliance Co. Ltd. (NYSE:YMM) gained 15.8% to close at $8.30.
    • Ollie's Bargain Outlet Holdings, Inc. (NASDAQ:OLLI) climbed 15.7% to close at $49.56 after Wells Fargo upgraded the stock from Equal-Weight to Overweight and announced a $65 price target.
    • iHuman Inc. (NYSE:IH) jumped 15.6% to close at $2.43.
    • Pinduoduo Inc. (NASDAQ:PDD) climbed 15.6% to close at $49.30 following a potential rule change which would allow Chinese companies to share sensitive data with US regulators, thus lowering risk of delisting.
    • RCM Technologies, Inc. (NASDAQ:RCMT) climbed 15% to close at $12.59.
    • Biophytis SA (NASDAQ:BPTS) gained 14.7% to close at $2.57.
    • Inozyme Pharma, Inc. (NASDAQ:INZY) rose 14.1% to close at $4.30 as the company announced preliminary biomarker, safety, and pharmacokinetic (PK) data from the first three patients treated in the Phase 1 portion of its Phase 1/2 trial of INZ-701 in ENPP1 Deficiency.
    • Borr Drilling Limited (NYSE:BORR) climbed 13.3% to close at $4.59.
    • The RealReal, Inc. (NASDAQ:REAL) gained 11.8% to close at $8.07.
    • SPI Energy Co., Ltd. (NASDAQ:SPI) climbed 11.6% to close at $3.17 after reporting record revenue of $162 million for 2021.
    • Context Therapeutics Inc. (NASDAQ:CNTX) shares jumped 10.8% to settle at $2.66 after jumping over 10% on Friday. Context Therapeutics recently posted FY21 net loss of $10.5 million.
    • Array Technologies, Inc. (NASDAQ:ARRY) gained 9% to close at $11.92 after the company announced it will supply advanced tracker technology for "the largest solar + storage project in the US."
    • Clovis Oncology, Inc. (NASDAQ:CLVS) gained 8.8% to close at $2.72.
    • TMC the metals company Inc. (NASDAQ:TMC) climbed 8.6% to close at $2.66.
    • Borqs Technologies, Inc. (NASDAQ:BRQS) gained 8.1% to settle at $0.2270. TDR Capital reported a new stake of 9.9% in Borqs Technologies.

     

    Don’t forget to check out our premarket coverage here .

    Losers

    • Curis, Inc. (NASDAQ:CRIS) shares fell 33.3% to close at $1.62 on Monday. The FDA has placed a partial clinical hold on Curis Inc's TakeAim Leukemia Phase 1/2a study in relapsed or refractory (R/R) acute myeloid leukemia (AML) or high-risk myelodysplastic syndrome (MDS).
    • Forge Global Holdings, Inc. (NYSE:FRGE) dipped 21.8% to close at $23.20.
    • GWG Holdings, Inc. (NASDAQ:GWGH) fell 21% to close at $4.22.
    • Snow Lake Resources Ltd. (NASDAQ:LITM) fell 19.3% to close at $8.10.
    • Art's-Way Manufacturing Co., Inc. (NASDAQ:ARTW) dipped 18.5% to close at $4.54. Art's Way Manufacturing announced an 8.9% year-over-year increase in agricultural products segment revenue for Q1.
    • Longeveron Inc. (NASDAQ:LGVN) dropped 17.7% to settle at $12.85. A leading medical journal published study of Longeveron's Phase 1 trial results for Alzheimer's disease.
    • Insignia Systems, Inc. (NASDAQ:ISIG) dropped 16.8% to settle at $10.56.
    • Clarus Therapeutics Holdings, Inc. (NASDAQ:CRXT) declined 16.8% to close at $1.24. Clarus Therapeutics recently reported Q4 earnings results.
    • Weidai Ltd. (NYSE:WEI) fell 16.1% to close at $1.20 after jumping 29% on Friday.
    • Expion360 Inc. (NASDAQ:XPON) dipped 15.9% to close at $6.67. This new issue opened for trade on Friday of last week.
    • Yunhong CTI Ltd. (NASDAQ:CTIB) dropped 15.8% to close at $1.12.
    • AeroClean Technologies, Inc. (NASDAQ:AERC) fell 15.3% to close at $3.88. AeroClean Technologies recently posted a Q4 loss of $0.13 per share.
    • Iveda Solutions, Inc. (NASDAQ:IVDA) fell 14.3% to close at $3.23. Iveda reported pricing of $8.0 million public offering, uplisting to Nasdaq and reverse stock split.
    • Recruiter.com Group, Inc. (NASDAQ:RCRT) dipped 14.2% to settle at $2.12.
    • Vertex Energy, Inc. (NASDAQ:VTNR) dropped 12.5% to close at $8.67.
    • Matson, Inc. (NASDAQ:MATX) dipped 11.5% to close at $102.25.
    • NextDecade Corporation (NASDAQ:NEXT) fell 11.1% to close at $6.17. Credit Suisse recently downgraded NextDecade from Outperform to Neutral and raised the price target from $3 to $7.5.
    • Rail Vision Ltd. (NASDAQ:RVSN) declined 10.3% to close at $2.44 following Thursday's IPO.
    • Digital World Acquisition Corp. (NASDAQ:DWAC) fell 10% to settle at $56.94 amid Tesla CEO Elon Musk purchasing a 9.2% stake in competitor Twitter.
    • Sharps Compliance Corp. (NASDAQ:SMED) fell 5.9% to close at $5.40. Sharps Compliance named Pat Mulloy as CEO.
    Get the next $AERC alert in real time by email

    Crush Q1 2026 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $AERC
    $ARRY
    $ARTW
    $ATER

    CompanyDatePrice TargetRatingAnalyst
    NextDecade Corporation
    $NEXT
    2/6/2026$7.00Overweight
    CapitalOne
    Jumia Technologies AG
    $JMIA
    2/6/2026$18.00Overweight
    Cantor Fitzgerald
    Futu Holdings Limited
    $FUTU
    2/2/2026$213.39Neutral → Buy
    Goldman
    Array Technologies Inc.
    $ARRY
    1/28/2026$11.00Outperform → Neutral
    Robert W. Baird
    IO Biotech Inc.
    $IOBT
    1/26/2026$0.50Overweight → Neutral
    Piper Sandler
    Tempest Therapeutics Inc.
    $TPST
    1/22/2026$11.00Neutral → Buy
    H.C. Wainwright
    Full Truck Alliance Co. Ltd.
    $YMM
    1/12/2026Neutral → Underweight
    Analyst
    Array Technologies Inc.
    $ARRY
    1/9/2026$12.00Hold → Buy
    TD Cowen
    More analyst ratings

    $AERC
    $ARRY
    $ARTW
    $ATER
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Amendment: Chief Operating Officer Sabet Ahmed Zaki bought $468 worth of shares (20 units at $23.40), increasing direct ownership by 2% to 1,015 units (SEC Form 4)

    4/A - Precipio, Inc. (0001043961) (Issuer)

    1/20/26 4:22:27 PM ET
    $PRPO
    Biotechnology: Laboratory Analytical Instruments
    Industrials

    Amendment: Chief Operating Officer Sabet Ahmed Zaki bought $488 worth of shares (25 units at $19.50), increasing direct ownership by 3% to 995 units (SEC Form 4)

    4/A - Precipio, Inc. (0001043961) (Issuer)

    1/20/26 4:21:46 PM ET
    $PRPO
    Biotechnology: Laboratory Analytical Instruments
    Industrials

    Amendment: Chief Operating Officer Sabet Ahmed Zaki bought $505 worth of shares (31 units at $16.30), increasing direct ownership by 3% to 970 units (SEC Form 4)

    4/A - Precipio, Inc. (0001043961) (Issuer)

    1/20/26 4:19:49 PM ET
    $PRPO
    Biotechnology: Laboratory Analytical Instruments
    Industrials

    $AERC
    $ARRY
    $ARTW
    $ATER
    SEC Filings

    View All

    Tempest Therapeutics Inc. filed SEC Form 8-K: Completion of Acquisition or Disposition of Assets, Entry into a Material Definitive Agreement, Unregistered Sales of Equity Securities, Changes in Control of Registrant

    8-K - Tempest Therapeutics, Inc. (0001544227) (Filer)

    2/6/26 4:12:27 PM ET
    $TPST
    Biotechnology: Pharmaceutical Preparations
    Health Care

    SEC Form SCHEDULE 13G filed by IO Biotech Inc.

    SCHEDULE 13G - IO Biotech, Inc. (0001865494) (Subject)

    2/6/26 4:10:31 PM ET
    $IOBT
    Biotechnology: Pharmaceutical Preparations
    Health Care

    SEC Form 6-K filed by Rail Vision Ltd.

    6-K - Rail Vision Ltd. (0001743905) (Filer)

    2/6/26 4:00:21 PM ET
    $RVSN
    Railroads
    Industrials

    $AERC
    $ARRY
    $ARTW
    $ATER
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    SEC Form 4 filed by CHIEF FINANCIAL OFFICER Mccall Patrick

    4 - IN8BIO, INC. (0001740279) (Issuer)

    2/6/26 4:30:26 PM ET
    $INAB
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care

    SEC Form 4 filed by President and COO Rochlin Kate

    4 - IN8BIO, INC. (0001740279) (Issuer)

    2/6/26 4:30:23 PM ET
    $INAB
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care

    SEC Form 4 filed by EVP and CSO Lamb Lawrence

    4 - IN8BIO, INC. (0001740279) (Issuer)

    2/6/26 4:30:27 PM ET
    $INAB
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care

    $AERC
    $ARRY
    $ARTW
    $ATER
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    CapitalOne initiated coverage on NextDecade with a new price target

    CapitalOne initiated coverage of NextDecade with a rating of Overweight and set a new price target of $7.00

    2/6/26 8:35:07 AM ET
    $NEXT
    Oil & Gas Production
    Utilities

    Cantor Fitzgerald initiated coverage on Jumia with a new price target

    Cantor Fitzgerald initiated coverage of Jumia with a rating of Overweight and set a new price target of $18.00

    2/6/26 8:11:07 AM ET
    $JMIA
    Catalog/Specialty Distribution
    Consumer Discretionary

    Futu Holdings upgraded by Goldman with a new price target

    Goldman upgraded Futu Holdings from Neutral to Buy and set a new price target of $213.39

    2/2/26 6:47:07 AM ET
    $FUTU
    Investment Bankers/Brokers/Service
    Finance

    $AERC
    $ARRY
    $ARTW
    $ATER
    FDA approvals

    Live FDA approvals issued by the Food and Drug Administration and FDA breaking news

    View All

    FDA Approval for RUBRACA issued to CLOVIS ONCOLOGY INC

    Submission status for CLOVIS ONCOLOGY INC's drug RUBRACA (SUPPL-13) with active ingredient RUCAPARIB CAMSYLATE has changed to 'Approval' on 12/21/2022. Application Category: NDA, Application Number: 209115, Application Classification: Efficacy

    12/22/22 4:37:40 AM ET
    $CLVS
    Biotechnology: Pharmaceutical Preparations
    Health Care

    FDA Approval for RUBRACA issued to CLOVIS ONCOLOGY INC

    Submission status for CLOVIS ONCOLOGY INC's drug RUBRACA (SUPPL-11) with active ingredient RUCAPARIB CAMSYLATE has changed to 'Approval' on 06/10/2022. Application Category: NDA, Application Number: 209115, Application Classification: Efficacy

    6/13/22 2:20:18 PM ET
    $CLVS
    Biotechnology: Pharmaceutical Preparations
    Health Care

    $AERC
    $ARRY
    $ARTW
    $ATER
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    Rail Vision Advances Strategic Collaboration with Israel Railways Cargo Division

    With its MainLine product already installed on Israel Railways' locomotives, this collaboration aims to expand Rail Vision's product offering by deploying its ShuntingYard product within Israel Railways' cargo division Ra'anana, Israel, Feb. 06, 2026 (GLOBE NEWSWIRE) -- Rail Vision Ltd. (NASDAQ:RVSN) ("Rail Vision" or the "Company"), an early commercialization stage technology company seeking to revolutionize railway safety and the data-related market, announced today its advancement to the next phase of its collaboration with Israel Railways. As previously announced, Israel Railways purchased and installed Rail Vision's MainLine systems on its locomotives and this advancement marks the

    2/6/26 8:32:00 AM ET
    $RVSN
    Railroads
    Industrials

    Drone Survey Operations Drive Scalable Growth in Drones as a Service (DaaS)

    NEW YORK, Feb. 05, 2026 (GLOBE NEWSWIRE) -- Market News Updates News Commentary - Survey Operations delivered through a Drones as a Service (DaaS) model are quickly becoming a preferred solution for industries that rely on accurate, real-time data. Construction, infrastructure, mining, agriculture, and energy companies are increasingly using drones to perform land surveys, site mapping, and inspections faster and at a lower cost than traditional methods. Instead of owning and operating their own drone fleets, customers can access advanced aerial surveying on demand, improving safety, reducing project timelines, and gaining higher-quality data to support better decision-making. Active Compa

    2/5/26 9:35:00 AM ET
    $DPRO
    $LTRX
    $ONDS
    Aerospace
    Industrials
    Computer Communications Equipment
    Telecommunications

    Longeveron Applauds Passage of the Mikaela Naylon Give Kids a Chance Act and Reauthorization of Rare Pediatric Disease Priority Review Voucher Program

    The Mikaela Naylon Give Kids a Chance Act reauthorizes the Pediatric Priority Review Voucher (PPRV) Program and extends eligibility for medicines achieving U.S. FDA approval before September 2029The Pediatric Priority Review Voucher program encourages the development of treatments for rare pediatric diseasesU.S. FDA has awarded Longeveron's laromestrocel Hypoplastic Left Heart Syndrome (HLHS) program Rare Pediatric Disease designation, Orphan Drug designation, and Fast Track designationWith the extension of the PPRV Program, Longeveron may be granted a Priority Review Voucher if laromestrocel's Biological License Application (BLA) is approved by the FDA before September 2029 MIAMI, Feb. 05

    2/5/26 9:15:00 AM ET
    $LGVN
    Biotechnology: Pharmaceutical Preparations
    Health Care

    $AERC
    $ARRY
    $ARTW
    $ATER
    Leadership Updates

    Live Leadership Updates

    View All

    Protalix Biotherapeutics and Secarna Pharmaceuticals Enter into Collaboration and Option Agreement

    Partnership combines Protalix's rare disease and biologics expertise with Secarna's AI–powered OligoCreator® platform to jointly develop pharmaceutical candidates for rare renal indications Protalix is granted an exclusive option to license any active compounds derived from the research for potential clinical development and commercialization CARMIEL, Israel and MARTINSRIED, Germany, Dec. 17, 2025 /PRNewswire/ -- Protalix BioTherapeutics, Inc. (NYSE American: PLX), a biopharmaceutical company focused on the discovery, development, production and commercialization of innovative therapeutics for rare diseases with significant unmet needs, and Secarna Pharmaceuticals GmbH & Co. KG, a company re

    12/17/25 6:50:00 AM ET
    $PLX
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care

    Red Cat Announces Key Leadership Transitions

    SAN JUAN, Puerto Rico, Dec. 02, 2025 (GLOBE NEWSWIRE) -- Red Cat Holdings, Inc. (NASDAQ:RCAT) ("Red Cat" or the "Company"), a U.S.-based provider of advanced all-domain drone and robotic solutions for defense and national security, today announced two strategic leadership transitions designed to strengthen operational execution and financial performance as the Company accelerates growth. Christian Ericson, Red Cat's current Chief Financial Officer (CFO), has been promoted to the new role of Chief Operating Officer (COO). Ericson joined Red Cat in March 2025 as Chief Financial Officer and has played a pivotal role in advancing Red Cat's financial foundation and operational capabilities. In

    12/2/25 4:05:00 PM ET
    $RCAT
    Computer Software: Prepackaged Software
    Technology

    Expion360 Appoints Joseph Hammer as Chief Executive Officer and Chairman of the Board

    Veteran Financial Executive and Board Director to Lead Strategic Direction and Next Phase of Growth  REDMOND, Ore., Oct. 28, 2025 (GLOBE NEWSWIRE) -- Expion360 Inc. (NASDAQ:XPON) ("Expion360" or the "Company"), an industry leader in lithium-ion battery power storage, today announced the appointment of Joseph Hammer as Chief Executive Officer and Chairman of the Board of Directors, effective October 16, 2025, succeeding Brian Schaffner, Chief Executive Officer, and Paul Shoun, President and Chairman of the Board, both of whom have stepped down from their respective roles at the Company. Mr. Schaffner will serve as a member of the Board of Directors. Joseph Hammer brings over 20 years' exp

    10/28/25 8:31:00 AM ET
    $XPON
    Industrial Machinery/Components
    Miscellaneous

    $AERC
    $ARRY
    $ARTW
    $ATER
    Financials

    Live finance-specific insights

    View All

    ARRAY Technologies Announces Fourth Quarter and Full Year 2025 Earnings Release Date and Conference Call

    ALBUQUERQUE, N.M., Feb. 04, 2026 (GLOBE NEWSWIRE) -- ARRAY Technologies, Inc. (the "Company" or "ARRAY") (NASDAQ:ARRY), a leading global provider of solar tracking technology products, software, services and foundation solutions, today announced that the Company will release its fourth quarter and full year 2025 results after the market closes on Wednesday, February 25, 2026, to be followed by a conference call at 5:00 p.m. (Eastern Time) that same day. The conference call can be accessed live over the phone by dialing (877)-869-3847 (domestic) or (201)-689-8261 (international), or via webcast of the live conference call by logging onto the Investor Relations section of the Company's webs

    2/4/26 4:05:00 PM ET
    $ARRY
    Miscellaneous manufacturing industries
    Consumer Discretionary

    Borr Drilling Limited - Invitation to Webcast and Conference Call for Q4 2025 Results

    HAMILTON, Bermuda, Jan. 30, 2026 /PRNewswire/ -- Borr Drilling Limited (NYSE and Euronext Growth Oslo: BORR) (the "Company") plans to release its financial results for the fourth quarter of 2025 after the close of the New York Stock Exchange on Wednesday, February 18, 2026. A conference call and webcast are scheduled for 09:00 New York time (15:00 CET) on Thursday, February 19, 2026. The earnings report, webcast and accompanying presentation will be available on the Investor Relations section of the Company's website, www.borrdrilling.com. In order to listen to the live presentation, participants may do one of the following: a)    Webcast To access the webcast, please go to the following l

    1/30/26 10:09:00 AM ET
    $BORR
    Oil & Gas Production
    Energy

    NOBLE CORPORATION PLC COMPLETES SALE OF FIVE JACKUPS TO BORR DRILLING

    HOUSTON, Jan. 28, 2026 /PRNewswire/ -- Noble Corporation plc (NYSE:NE, ", Noble", , or the ", Company", )) today announced that it has completed the sale of five jackup rigs to Borr Drilling Limited (NYSE:BORR, ", Borr", )) for $360 million. The Company generated approximately $210 million in cash plus $150 million in seller notes from the sale of the Noble Tom Prosser, Noble Mick O'Brien, Noble Regina Allen, Noble Resilient and Noble Resolute. Noble intends to operate two rigs – Noble Mick O'Brien and Noble Resolute – under a bareboat charter agreement with Borr until December 2026, as well as the Noble Resilient through the remainder of its current contract term (including exercise of any

    1/28/26 5:08:00 PM ET
    $BORR
    $NE
    Oil & Gas Production
    Energy

    $AERC
    $ARRY
    $ARTW
    $ATER
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    SEC Form SC 13G filed by Inozyme Pharma Inc.

    SC 13G - Inozyme Pharma, Inc. (0001693011) (Subject)

    12/9/24 4:14:49 PM ET
    $INZY
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Amendment: SEC Form SC 13G/A filed by Red Cat Holdings Inc.

    SC 13G/A - Red Cat Holdings, Inc. (0000748268) (Subject)

    12/6/24 4:32:04 PM ET
    $RCAT
    Computer Software: Prepackaged Software
    Technology

    Amendment: SEC Form SC 13D/A filed by iQIYI Inc.

    SC 13D/A - iQIYI, Inc. (0001722608) (Subject)

    12/4/24 8:11:53 AM ET
    $IQ
    Consumer Electronics/Video Chains
    Consumer Discretionary